Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Rhea-AI Summary
Haemonetics (NYSE: HAE) will publish fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026. A conference call with investors and analysts is scheduled for 8:00 am ET on May 7, 2026.
Participants can join via teleconference after registration to receive a dial-in number and personalized PIN. A live webcast will be available on Haemonetics' investor relations website and a replay will be accessible for one year starting May 7, 2026 at 11:00 am ET.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – HAE
On the day this news was published, HAE gained 1.05%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 07 | Earnings date set | Neutral | +1.3% | Announced Q3 FY26 results release timing and related conference call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date scheduling news was followed by a modest positive move, suggesting such updates have historically been absorbed without major dislocations.
Recent news for Haemonetics centers on product approvals, portfolio reshaping, and regular earnings communications. On Jan 7, 2026, the company similarly announced the release timetable for third quarter fiscal 2026 results with a conference call and year-long replay. That announcement saw a 1.25% 24-hour move. Today’s fourth quarter and full-year 2026 earnings date notice fits this pattern of advance scheduling and standard investor-relations practice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call can be accessed via teleconference at: Q4 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/7d678otf
A replay of the conference call and webcast will be available for one year beginning on May 7, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of
hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | ||
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations | |
(781) 356-9763 | (203) 733-4987 | |
Media Contact: | ||
Josh Gitelson, Sr. Director-Global Communications | ||
(781) 356-9776 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2026-results-may-7-2026-302731954.html
SOURCE Haemonetics Corporation